4//SEC Filing
Hite Christopher 4
Accession 0000950103-21-004602
CIK 0001802768other
Filed
Mar 24, 8:00 PM ET
Accepted
Mar 25, 7:53 PM ET
Size
5.9 KB
Accession
0000950103-21-004602
Insider Transaction Report
Form 4
Hite Christopher
EVP & Vice Chairman
Transactions
- Sale
LP interests in RPI US Partners 2019, LP
2021-03-23$469.86/sh−31,959$15,016,224→ 30,541 totalExercise: $0.00→ Class A Ordinary Shares (319,590 underlying)
Footnotes (2)
- [F1]Represents limited partnership interests in RPI US Partners 2019, LP ("RPI US LP Interests"). Each RPI US LP Interest can be exchanged for ten Class B Interests in Royalty Pharma Holdings, Ltd. ("Holdings") at any time and for no additional value, which exchange right does not expire until so converted. Each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged upon such exchange for one Class A Ordinary Share of the Issuer for no additional value.
- [F2]These RPI US LP Interests were withheld to cover tax withholding obligations.
Documents
Issuer
Royalty Pharma plc
CIK 0001802768
Entity typeother
Related Parties
1- filerCIK 0001814238
Filing Metadata
- Form type
- 4
- Filed
- Mar 24, 8:00 PM ET
- Accepted
- Mar 25, 7:53 PM ET
- Size
- 5.9 KB